Skip to main content
SP5007,671.92+0.25%DOW53,492.33+0.14%NASDAQ26,126.56+0.56%BTC$79,378.00+0.01%ETH$2,478.39-0.89%GOLD$4,709.30+0.24%OIL$82.09-3.43%
Smart Investors Daily
Sign InSign Up Free
CU

NASDAQ · CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Healthcare · Biotechnology

$2.73

Up+$0.15 (+5.49%)

Updated Aug 25, 2026, 4:12 PM

SID Score

5.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
10.3M
P/E ratio
-9.13
Dividend yield
0.00%
52-week range
$0.22 – $14.80
Volume
3.04K
Avg. volume
228.34K

Price performance

CUPR price history

1M range · 0 trading sessions · Daily adjusted prices

CUPR does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest CUPR news

The latest Smart Investors Daily articles mentioning CUPR.

Stock researchCompany · Overview

CUPR research

Overview

Company profile and research snapshot.

Company profile

Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By